OasisLMS

This Trauma session was recorded live at the 2025 AANS Annual Scientific Meeting.

This session features a panel of leading experts to explore the complex challenges and evolving strategies in managing repeat brain injuries. Attendees will gain insights into cutting-edge research, clinical advancements and multidisciplinary approaches to improving outcomes for patients with recurrent traumatic brain injuries. The session also features the prestigious Chuck Koll Lecture that will provide a deep dive into the latest innovations and trends.

Speakers: Tanvir Choudhri, Peter Hutchinson, David Okonkwo, P. Raksin, Berje Shammassian, Martina Stippler, Shelly Timmons, Edie Zusman

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The last date to claim credit is 06/26/2027.

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Those who have disclosed a relationship with ineligible companies are listed below.

All disclosed financial relationships have been mitigated in accordance with ACCME standards.

Name	Relationship/Company
Tanvir Choudhri	BK Meditech: Advisor (Ongoing), Royalty Recipient (Ongoing), Stock Options (Ongoing); SGN Nanopharma: Advisor (Ongoing), Ownership Interest (Ongoing), Stock Options (Ongoing)
David Okonkwo	Highridge: Royalty Recipient (Ongoing); NuVasive: Consultant (Ongoing), Royalty Recipient (Ongoing)

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.